![Deborah S. Lorenz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Deborah S. Lorenz
Nessuna posizione attualmente
Profilo
Deborah S.
Lorenz worked as Director-Investor Relations & Communications at Molecular Insight Pharmaceuticals, Inc. and as VP-Investor Relations & Corporate Communications at Lipid Sciences, Inc.
Precedenti posizioni note di Deborah S. Lorenz
Società | Posizione | Fine |
---|---|---|
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Public Communications Contact | - |
Lipid Sciences, Inc.
![]() Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Lipid Sciences, Inc.
![]() Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Commercial Services |
Molecular Insight Pharmaceuticals, Inc.
![]() Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
- Borsa valori
- Insiders
- Deborah S. Lorenz